cleaved caspase3  (Bio-Techne corporation)


Bioz Verified Symbol Bio-Techne corporation is a verified supplier
Bioz Manufacturer Symbol Bio-Techne corporation manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Bio-Techne corporation cleaved caspase3
    Cleaved Caspase3, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cleaved caspase3/product/Bio-Techne corporation
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    cleaved caspase3 - by Bioz Stars, 2024-09
    93/100 stars

    Images

    haltrich 2007 thermus sp  (ATCC)


    Bioz Verified Symbol ATCC is a verified supplier
    Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    ATCC haltrich 2007 thermus sp
    Haltrich 2007 Thermus Sp, supplied by ATCC, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/haltrich 2007 thermus sp/product/ATCC
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    haltrich 2007 thermus sp - by Bioz Stars, 2024-09
    92/100 stars

    Images

    cleaved caspase3  (Bio-Techne corporation)


    Bioz Verified Symbol Bio-Techne corporation is a verified supplier
    Bioz Manufacturer Symbol Bio-Techne corporation manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Bio-Techne corporation cleaved caspase3
    Cleaved Caspase3, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cleaved caspase3/product/Bio-Techne corporation
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    cleaved caspase3 - by Bioz Stars, 2024-09
    93/100 stars

    Images

    emd 15840  (Thermo Fisher)


    Bioz Verified Symbol Thermo Fisher is a verified supplier
    Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Thermo Fisher emd 15840
    Emd 15840, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/emd 15840/product/Thermo Fisher
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    emd 15840 - by Bioz Stars, 2024-09
    86/100 stars

    Images

    haltrich 2007 thermus sp  (ATCC)


    Bioz Verified Symbol ATCC is a verified supplier
    Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    ATCC haltrich 2007 thermus sp
    Haltrich 2007 Thermus Sp, supplied by ATCC, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/haltrich 2007 thermus sp/product/ATCC
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    haltrich 2007 thermus sp - by Bioz Stars, 2024-09
    92/100 stars

    Images

    rabbit polyclonal anti cdh1  (Novus Biologicals)


    Bioz Verified Symbol Novus Biologicals is a verified supplier
    Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 91

    Structured Review

    Novus Biologicals rabbit polyclonal anti cdh1
    <t>APC/C-Cdh1</t> mediates TORC1 inactivation-induced anaphase onset (A) Cells of strain SCU1712 (CLB5-TAP) were treated as described in <xref ref-type=Figure 1 A. TAP-tagged cyclin B5 (Clb5) was detected by western blotting analysis using the anti-TAP antibody (PAP). (B–D) Cells of strains SCU1485 (BUB1-GFP) and SCU1337 (MAD2-GFP) harboring plasmid pSCU1701 (pMTW1-RFP) were treated as described in Figure 1 C. Bub1-GFP and Mad2-GFP signals were captured with Mtw1-RFP (a kinetochore marker) signals. Scale bar, 2.5 μm. Percentages of cells with Bub1-GFP or Mad2-GFP on the kinetochore were determined, and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ns, not statistically significant. (E) Cells of strains SCU2755 (PDS1-3HA) and SCU2693 (PDS1-3HA cdc20-3) precultured at 25°C were arrested in metaphase by nocodazole treatment for 3 h and transferred to 37°C for 30 min. Thereafter, cells were treated with rapamycin (+Rap) or released into nocodazole-free media (-Noc) (Time 0). Cells of strain SCU2282 (PDS1-3HA cdh1Δ) were treated as described in Figure 1 A. For comparison, see Figure 1 A, WT. 3HA-tagged securin Pds1 was detected by western blotting analysis using the anti-HA antibody. (F) Cells of strains SCU69 (CEN4-GFP) and SCU2114 (CEN4-GFP cdh1Δ) were treated as described in Figure 1 C. Scale bar, 2.5 μm. Percentages of cells with separated sister chromatids were determined and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗, p <0.05. (G) Five-fold serial dilutions of cells were spotted in 1-μL drops onto YPAD plates with or without 5 ng/mL rapamycin. The plates were incubated at 30°C for 1 day for YPAD plates and 2 days for rapamycin-containing YPAD plates. The yeast strains SCU893 (wild type) and SCU1228 (cdh1Δ) were used. (H) Model of APC/C-Cdh1 mediating TORC1 inactivation-induced anaphase onset. The inactivation of TORC1 sequentially causes APC/C-Cdh1 activation, degradation of securin and cyclin B5, and anaphase onset. " width="250" height="auto" />
    Rabbit Polyclonal Anti Cdh1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti cdh1/product/Novus Biologicals
    Average 91 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    rabbit polyclonal anti cdh1 - by Bioz Stars, 2024-09
    91/100 stars

    Images

    1) Product Images from "TORC1 inactivation promotes APC/C-dependent mitotic slippage in yeast and human cells"

    Article Title: TORC1 inactivation promotes APC/C-dependent mitotic slippage in yeast and human cells

    Journal: iScience

    doi: 10.1016/j.isci.2021.103675

    APC/C-Cdh1 mediates TORC1 inactivation-induced anaphase onset (A) Cells of strain SCU1712 (CLB5-TAP) were treated as described in <xref ref-type=Figure 1 A. TAP-tagged cyclin B5 (Clb5) was detected by western blotting analysis using the anti-TAP antibody (PAP). (B–D) Cells of strains SCU1485 (BUB1-GFP) and SCU1337 (MAD2-GFP) harboring plasmid pSCU1701 (pMTW1-RFP) were treated as described in Figure 1 C. Bub1-GFP and Mad2-GFP signals were captured with Mtw1-RFP (a kinetochore marker) signals. Scale bar, 2.5 μm. Percentages of cells with Bub1-GFP or Mad2-GFP on the kinetochore were determined, and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ns, not statistically significant. (E) Cells of strains SCU2755 (PDS1-3HA) and SCU2693 (PDS1-3HA cdc20-3) precultured at 25°C were arrested in metaphase by nocodazole treatment for 3 h and transferred to 37°C for 30 min. Thereafter, cells were treated with rapamycin (+Rap) or released into nocodazole-free media (-Noc) (Time 0). Cells of strain SCU2282 (PDS1-3HA cdh1Δ) were treated as described in Figure 1 A. For comparison, see Figure 1 A, WT. 3HA-tagged securin Pds1 was detected by western blotting analysis using the anti-HA antibody. (F) Cells of strains SCU69 (CEN4-GFP) and SCU2114 (CEN4-GFP cdh1Δ) were treated as described in Figure 1 C. Scale bar, 2.5 μm. Percentages of cells with separated sister chromatids were determined and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗, p <0.05. (G) Five-fold serial dilutions of cells were spotted in 1-μL drops onto YPAD plates with or without 5 ng/mL rapamycin. The plates were incubated at 30°C for 1 day for YPAD plates and 2 days for rapamycin-containing YPAD plates. The yeast strains SCU893 (wild type) and SCU1228 (cdh1Δ) were used. (H) Model of APC/C-Cdh1 mediating TORC1 inactivation-induced anaphase onset. The inactivation of TORC1 sequentially causes APC/C-Cdh1 activation, degradation of securin and cyclin B5, and anaphase onset. " title="APC/C-Cdh1 mediates TORC1 inactivation-induced anaphase onset (A) Cells of ..." property="contentUrl" width="100%" height="100%"/>
    Figure Legend Snippet: APC/C-Cdh1 mediates TORC1 inactivation-induced anaphase onset (A) Cells of strain SCU1712 (CLB5-TAP) were treated as described in Figure 1 A. TAP-tagged cyclin B5 (Clb5) was detected by western blotting analysis using the anti-TAP antibody (PAP). (B–D) Cells of strains SCU1485 (BUB1-GFP) and SCU1337 (MAD2-GFP) harboring plasmid pSCU1701 (pMTW1-RFP) were treated as described in Figure 1 C. Bub1-GFP and Mad2-GFP signals were captured with Mtw1-RFP (a kinetochore marker) signals. Scale bar, 2.5 μm. Percentages of cells with Bub1-GFP or Mad2-GFP on the kinetochore were determined, and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ns, not statistically significant. (E) Cells of strains SCU2755 (PDS1-3HA) and SCU2693 (PDS1-3HA cdc20-3) precultured at 25°C were arrested in metaphase by nocodazole treatment for 3 h and transferred to 37°C for 30 min. Thereafter, cells were treated with rapamycin (+Rap) or released into nocodazole-free media (-Noc) (Time 0). Cells of strain SCU2282 (PDS1-3HA cdh1Δ) were treated as described in Figure 1 A. For comparison, see Figure 1 A, WT. 3HA-tagged securin Pds1 was detected by western blotting analysis using the anti-HA antibody. (F) Cells of strains SCU69 (CEN4-GFP) and SCU2114 (CEN4-GFP cdh1Δ) were treated as described in Figure 1 C. Scale bar, 2.5 μm. Percentages of cells with separated sister chromatids were determined and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗, p <0.05. (G) Five-fold serial dilutions of cells were spotted in 1-μL drops onto YPAD plates with or without 5 ng/mL rapamycin. The plates were incubated at 30°C for 1 day for YPAD plates and 2 days for rapamycin-containing YPAD plates. The yeast strains SCU893 (wild type) and SCU1228 (cdh1Δ) were used. (H) Model of APC/C-Cdh1 mediating TORC1 inactivation-induced anaphase onset. The inactivation of TORC1 sequentially causes APC/C-Cdh1 activation, degradation of securin and cyclin B5, and anaphase onset.

    Techniques Used: Western Blot, Plasmid Preparation, Marker, Two Tailed Test, Incubation, Activation Assay

    Cdc14 mediates TORC1 inactivation-induced anaphase onset (A) Cells of strain SCU3250 (PDS1-3HA cdc14-1) were treated as described in <xref ref-type=Figure 2 E. 3HA-tagged securin Pds1 was detected by western blotting analysis using the anti-HA antibody. (B and C) Cells of strains SCU69 (CEN4-GFP) and SCU3204 (CEN4-GFP cdc14-1) preincubated at 25°C were arrested in metaphase by nocodazole treatment for 3 h and then transferred to 37°C for 30 min. Thereafter, the cells were further incubated with or without rapamycin for 1 h. Scale bar, 2.5 μm. Percentages of cells with separated sister chromatids are shown in (C). For the control, cells were observed 30 min after nocodazole removal. Averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗, p < 0.05; ∗∗; p < 0.0001. (D and E) Cells of strain SCU1000 (CDC14-5GFP) were treated as described in Figure 1 C. Scale bar, 2.5 μm. Percentages of cells with diffused Cdc14 were determined and averages and SD from three independent experiments are shown in (E). For the control, cells were observed 30 min after nocodazole removal. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗∗∗∗, p <0.000001. (F) Five-fold serial dilutions of cells of strains SCU893 (wild type) and SCU1001 (cdc14-1) were spotted in 1-μL drops onto YPAD plates with or without 10 ng/mL rapamycin. The plates were incubated at 25°C for 3 days. An unrelated atg1Δ strain (SCU4067) defective in autophagy was used as the control. (G) Model of Cdc14 mediating TORC1 inactivation-induced anaphase onset. The inactivation of TORC1 sequentially causes Cdc14 activation, APC/C-Cdh1 activation, securin degradation, and anaphase onset. " title="... The inactivation of TORC1 sequentially causes Cdc14 activation, APC/C-Cdh1 activation, securin degradation, and anaphase onset. " property="contentUrl" width="100%" height="100%"/>
    Figure Legend Snippet: Cdc14 mediates TORC1 inactivation-induced anaphase onset (A) Cells of strain SCU3250 (PDS1-3HA cdc14-1) were treated as described in Figure 2 E. 3HA-tagged securin Pds1 was detected by western blotting analysis using the anti-HA antibody. (B and C) Cells of strains SCU69 (CEN4-GFP) and SCU3204 (CEN4-GFP cdc14-1) preincubated at 25°C were arrested in metaphase by nocodazole treatment for 3 h and then transferred to 37°C for 30 min. Thereafter, the cells were further incubated with or without rapamycin for 1 h. Scale bar, 2.5 μm. Percentages of cells with separated sister chromatids are shown in (C). For the control, cells were observed 30 min after nocodazole removal. Averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗, p < 0.05; ∗∗; p < 0.0001. (D and E) Cells of strain SCU1000 (CDC14-5GFP) were treated as described in Figure 1 C. Scale bar, 2.5 μm. Percentages of cells with diffused Cdc14 were determined and averages and SD from three independent experiments are shown in (E). For the control, cells were observed 30 min after nocodazole removal. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗∗∗∗, p <0.000001. (F) Five-fold serial dilutions of cells of strains SCU893 (wild type) and SCU1001 (cdc14-1) were spotted in 1-μL drops onto YPAD plates with or without 10 ng/mL rapamycin. The plates were incubated at 25°C for 3 days. An unrelated atg1Δ strain (SCU4067) defective in autophagy was used as the control. (G) Model of Cdc14 mediating TORC1 inactivation-induced anaphase onset. The inactivation of TORC1 sequentially causes Cdc14 activation, APC/C-Cdh1 activation, securin degradation, and anaphase onset.

    Techniques Used: Western Blot, Incubation, Two Tailed Test, Activation Assay

    mTORC1 inactivation elicits mitotic slippage (A) A schematic of the experimental procedure. (B) Phase-contrast time-lapse imaging of nocodazole-treated A549 cells. An example representing each category of cell fate to classify cells in <xref ref-type=Figure S4 A is shown. Numbers show elapsed time (hour:minute) relative to the start of imaging. Scale bar, 50 μm. (C) Fate of nocodazole-treated A549 cells with or without rapamycin treatment after 60-h imaging. Proportion of cells classified into each category, obtained by averaging the results of four independent experiments shown in Figure S4 A, is presented. Error bars represent standard errors. (D) Rate of mitotic slippage in nocodazole-treated A549 cells with or without rapamycin treatment and/or Cdh1 depletion. Percentage of cells that underwent mitotic slippage among the cells that underwent mitotic cell death or mitotic slippage, obtained by averaging the results of four independent experiments that are shown as dots, is presented. Error bars represent standard errors. ∗∗, p <0.01; ∗∗∗, p <0.001 (Tukey's multiple comparison test). ns, not statistically significant. (E) Duration of mitosis in nocodazole-treated A549 cells that underwent mitotic cell death or mitotic slippage. The results are average of four independent experiments. The results of rare mitotic slippage events in cells depleted of Cdc20 with or without Cdh1 were not shown. Error bars represent standard errors. ∗∗∗, p <0.001 (Tukey's multiple comparison test, comparison with Mock -Rap, mitotic cell death). (F) Duration of interphase after mitotic slippage in nocodazole-treated A549 cells with or without rapamycin treatment and/or Cdh1 depletion. The results are average of four independent experiments, which are shown as dots. Error bars represent standard errors. ∗∗, p <0.01 (Tukey's multiple comparison test). ns, not statistically significant. " title="... A549 cells with or without rapamycin treatment and/or Cdh1 depletion. Percentage of cells that underwent mitotic slippage ..." property="contentUrl" width="100%" height="100%"/>
    Figure Legend Snippet: mTORC1 inactivation elicits mitotic slippage (A) A schematic of the experimental procedure. (B) Phase-contrast time-lapse imaging of nocodazole-treated A549 cells. An example representing each category of cell fate to classify cells in Figure S4 A is shown. Numbers show elapsed time (hour:minute) relative to the start of imaging. Scale bar, 50 μm. (C) Fate of nocodazole-treated A549 cells with or without rapamycin treatment after 60-h imaging. Proportion of cells classified into each category, obtained by averaging the results of four independent experiments shown in Figure S4 A, is presented. Error bars represent standard errors. (D) Rate of mitotic slippage in nocodazole-treated A549 cells with or without rapamycin treatment and/or Cdh1 depletion. Percentage of cells that underwent mitotic slippage among the cells that underwent mitotic cell death or mitotic slippage, obtained by averaging the results of four independent experiments that are shown as dots, is presented. Error bars represent standard errors. ∗∗, p <0.01; ∗∗∗, p <0.001 (Tukey's multiple comparison test). ns, not statistically significant. (E) Duration of mitosis in nocodazole-treated A549 cells that underwent mitotic cell death or mitotic slippage. The results are average of four independent experiments. The results of rare mitotic slippage events in cells depleted of Cdc20 with or without Cdh1 were not shown. Error bars represent standard errors. ∗∗∗, p <0.001 (Tukey's multiple comparison test, comparison with Mock -Rap, mitotic cell death). (F) Duration of interphase after mitotic slippage in nocodazole-treated A549 cells with or without rapamycin treatment and/or Cdh1 depletion. The results are average of four independent experiments, which are shown as dots. Error bars represent standard errors. ∗∗, p <0.01 (Tukey's multiple comparison test). ns, not statistically significant.

    Techniques Used: Imaging


    Figure Legend Snippet:

    Techniques Used: Recombinant, Western Blot, Sequencing, Plasmid Preparation, Software


    Structured Review

    Addgene inc pypq144
    Pypq144, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pypq144/product/Addgene inc
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    pypq144 - by Bioz Stars, 2024-09
    92/100 stars

    Images


    Structured Review

    Addgene inc pypq145
    Pypq145, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pypq145/product/Addgene inc
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    pypq145 - by Bioz Stars, 2024-09
    92/100 stars

    Images


    Structured Review

    Addgene inc pypq141 zmubi rz aac
    Pypq141 Zmubi Rz Aac, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pypq141 zmubi rz aac/product/Addgene inc
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    pypq141 zmubi rz aac - by Bioz Stars, 2024-09
    92/100 stars

    Images


    Structured Review

    Addgene inc pypq143
    Pypq143, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pypq143/product/Addgene inc
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    pypq143 - by Bioz Stars, 2024-09
    92/100 stars

    Images


    Structured Review

    Addgene inc pypq141
    Pypq141, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pypq141/product/Addgene inc
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    pypq141 - by Bioz Stars, 2024-09
    92/100 stars

    Images


    Structured Review

    Addgene inc pypq146
    Pypq146, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pypq146/product/Addgene inc
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    pypq146 - by Bioz Stars, 2024-09
    92/100 stars

    Images

    rabbit polyclonal anti cdh1  (Novus Biologicals)


    Bioz Verified Symbol Novus Biologicals is a verified supplier
    Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 91

    Structured Review

    Novus Biologicals rabbit polyclonal anti cdh1
    <t>APC/C-Cdh1</t> mediates TORC1 inactivation-induced anaphase onset (A) Cells of strain SCU1712 (CLB5-TAP) were treated as described in <xref ref-type=Figure 1 A. TAP-tagged cyclin B5 (Clb5) was detected by western blotting analysis using the anti-TAP antibody (PAP). (B–D) Cells of strains SCU1485 (BUB1-GFP) and SCU1337 (MAD2-GFP) harboring plasmid pSCU1701 (pMTW1-RFP) were treated as described in Figure 1 C. Bub1-GFP and Mad2-GFP signals were captured with Mtw1-RFP (a kinetochore marker) signals. Scale bar, 2.5 μm. Percentages of cells with Bub1-GFP or Mad2-GFP on the kinetochore were determined, and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ns, not statistically significant. (E) Cells of strains SCU2755 (PDS1-3HA) and SCU2693 (PDS1-3HA cdc20-3) precultured at 25°C were arrested in metaphase by nocodazole treatment for 3 h and transferred to 37°C for 30 min. Thereafter, cells were treated with rapamycin (+Rap) or released into nocodazole-free media (-Noc) (Time 0). Cells of strain SCU2282 (PDS1-3HA cdh1Δ) were treated as described in Figure 1 A. For comparison, see Figure 1 A, WT. 3HA-tagged securin Pds1 was detected by western blotting analysis using the anti-HA antibody. (F) Cells of strains SCU69 (CEN4-GFP) and SCU2114 (CEN4-GFP cdh1Δ) were treated as described in Figure 1 C. Scale bar, 2.5 μm. Percentages of cells with separated sister chromatids were determined and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗, p <0.05. (G) Five-fold serial dilutions of cells were spotted in 1-μL drops onto YPAD plates with or without 5 ng/mL rapamycin. The plates were incubated at 30°C for 1 day for YPAD plates and 2 days for rapamycin-containing YPAD plates. The yeast strains SCU893 (wild type) and SCU1228 (cdh1Δ) were used. (H) Model of APC/C-Cdh1 mediating TORC1 inactivation-induced anaphase onset. The inactivation of TORC1 sequentially causes APC/C-Cdh1 activation, degradation of securin and cyclin B5, and anaphase onset. " width="250" height="auto" />
    Rabbit Polyclonal Anti Cdh1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti cdh1/product/Novus Biologicals
    Average 91 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    rabbit polyclonal anti cdh1 - by Bioz Stars, 2024-09
    91/100 stars

    Images

    1) Product Images from "TORC1 inactivation promotes APC/C-dependent mitotic slippage in yeast and human cells"

    Article Title: TORC1 inactivation promotes APC/C-dependent mitotic slippage in yeast and human cells

    Journal: iScience

    doi: 10.1016/j.isci.2021.103675

    APC/C-Cdh1 mediates TORC1 inactivation-induced anaphase onset (A) Cells of strain SCU1712 (CLB5-TAP) were treated as described in <xref ref-type=Figure 1 A. TAP-tagged cyclin B5 (Clb5) was detected by western blotting analysis using the anti-TAP antibody (PAP). (B–D) Cells of strains SCU1485 (BUB1-GFP) and SCU1337 (MAD2-GFP) harboring plasmid pSCU1701 (pMTW1-RFP) were treated as described in Figure 1 C. Bub1-GFP and Mad2-GFP signals were captured with Mtw1-RFP (a kinetochore marker) signals. Scale bar, 2.5 μm. Percentages of cells with Bub1-GFP or Mad2-GFP on the kinetochore were determined, and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ns, not statistically significant. (E) Cells of strains SCU2755 (PDS1-3HA) and SCU2693 (PDS1-3HA cdc20-3) precultured at 25°C were arrested in metaphase by nocodazole treatment for 3 h and transferred to 37°C for 30 min. Thereafter, cells were treated with rapamycin (+Rap) or released into nocodazole-free media (-Noc) (Time 0). Cells of strain SCU2282 (PDS1-3HA cdh1Δ) were treated as described in Figure 1 A. For comparison, see Figure 1 A, WT. 3HA-tagged securin Pds1 was detected by western blotting analysis using the anti-HA antibody. (F) Cells of strains SCU69 (CEN4-GFP) and SCU2114 (CEN4-GFP cdh1Δ) were treated as described in Figure 1 C. Scale bar, 2.5 μm. Percentages of cells with separated sister chromatids were determined and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗, p <0.05. (G) Five-fold serial dilutions of cells were spotted in 1-μL drops onto YPAD plates with or without 5 ng/mL rapamycin. The plates were incubated at 30°C for 1 day for YPAD plates and 2 days for rapamycin-containing YPAD plates. The yeast strains SCU893 (wild type) and SCU1228 (cdh1Δ) were used. (H) Model of APC/C-Cdh1 mediating TORC1 inactivation-induced anaphase onset. The inactivation of TORC1 sequentially causes APC/C-Cdh1 activation, degradation of securin and cyclin B5, and anaphase onset. " title="APC/C-Cdh1 mediates TORC1 inactivation-induced anaphase onset (A) Cells of ..." property="contentUrl" width="100%" height="100%"/>
    Figure Legend Snippet: APC/C-Cdh1 mediates TORC1 inactivation-induced anaphase onset (A) Cells of strain SCU1712 (CLB5-TAP) were treated as described in Figure 1 A. TAP-tagged cyclin B5 (Clb5) was detected by western blotting analysis using the anti-TAP antibody (PAP). (B–D) Cells of strains SCU1485 (BUB1-GFP) and SCU1337 (MAD2-GFP) harboring plasmid pSCU1701 (pMTW1-RFP) were treated as described in Figure 1 C. Bub1-GFP and Mad2-GFP signals were captured with Mtw1-RFP (a kinetochore marker) signals. Scale bar, 2.5 μm. Percentages of cells with Bub1-GFP or Mad2-GFP on the kinetochore were determined, and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ns, not statistically significant. (E) Cells of strains SCU2755 (PDS1-3HA) and SCU2693 (PDS1-3HA cdc20-3) precultured at 25°C were arrested in metaphase by nocodazole treatment for 3 h and transferred to 37°C for 30 min. Thereafter, cells were treated with rapamycin (+Rap) or released into nocodazole-free media (-Noc) (Time 0). Cells of strain SCU2282 (PDS1-3HA cdh1Δ) were treated as described in Figure 1 A. For comparison, see Figure 1 A, WT. 3HA-tagged securin Pds1 was detected by western blotting analysis using the anti-HA antibody. (F) Cells of strains SCU69 (CEN4-GFP) and SCU2114 (CEN4-GFP cdh1Δ) were treated as described in Figure 1 C. Scale bar, 2.5 μm. Percentages of cells with separated sister chromatids were determined and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗, p <0.05. (G) Five-fold serial dilutions of cells were spotted in 1-μL drops onto YPAD plates with or without 5 ng/mL rapamycin. The plates were incubated at 30°C for 1 day for YPAD plates and 2 days for rapamycin-containing YPAD plates. The yeast strains SCU893 (wild type) and SCU1228 (cdh1Δ) were used. (H) Model of APC/C-Cdh1 mediating TORC1 inactivation-induced anaphase onset. The inactivation of TORC1 sequentially causes APC/C-Cdh1 activation, degradation of securin and cyclin B5, and anaphase onset.

    Techniques Used: Western Blot, Plasmid Preparation, Marker, Two Tailed Test, Incubation, Activation Assay

    Cdc14 mediates TORC1 inactivation-induced anaphase onset (A) Cells of strain SCU3250 (PDS1-3HA cdc14-1) were treated as described in <xref ref-type=Figure 2 E. 3HA-tagged securin Pds1 was detected by western blotting analysis using the anti-HA antibody. (B and C) Cells of strains SCU69 (CEN4-GFP) and SCU3204 (CEN4-GFP cdc14-1) preincubated at 25°C were arrested in metaphase by nocodazole treatment for 3 h and then transferred to 37°C for 30 min. Thereafter, the cells were further incubated with or without rapamycin for 1 h. Scale bar, 2.5 μm. Percentages of cells with separated sister chromatids are shown in (C). For the control, cells were observed 30 min after nocodazole removal. Averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗, p < 0.05; ∗∗; p < 0.0001. (D and E) Cells of strain SCU1000 (CDC14-5GFP) were treated as described in Figure 1 C. Scale bar, 2.5 μm. Percentages of cells with diffused Cdc14 were determined and averages and SD from three independent experiments are shown in (E). For the control, cells were observed 30 min after nocodazole removal. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗∗∗∗, p <0.000001. (F) Five-fold serial dilutions of cells of strains SCU893 (wild type) and SCU1001 (cdc14-1) were spotted in 1-μL drops onto YPAD plates with or without 10 ng/mL rapamycin. The plates were incubated at 25°C for 3 days. An unrelated atg1Δ strain (SCU4067) defective in autophagy was used as the control. (G) Model of Cdc14 mediating TORC1 inactivation-induced anaphase onset. The inactivation of TORC1 sequentially causes Cdc14 activation, APC/C-Cdh1 activation, securin degradation, and anaphase onset. " title="... The inactivation of TORC1 sequentially causes Cdc14 activation, APC/C-Cdh1 activation, securin degradation, and anaphase onset. " property="contentUrl" width="100%" height="100%"/>
    Figure Legend Snippet: Cdc14 mediates TORC1 inactivation-induced anaphase onset (A) Cells of strain SCU3250 (PDS1-3HA cdc14-1) were treated as described in Figure 2 E. 3HA-tagged securin Pds1 was detected by western blotting analysis using the anti-HA antibody. (B and C) Cells of strains SCU69 (CEN4-GFP) and SCU3204 (CEN4-GFP cdc14-1) preincubated at 25°C were arrested in metaphase by nocodazole treatment for 3 h and then transferred to 37°C for 30 min. Thereafter, the cells were further incubated with or without rapamycin for 1 h. Scale bar, 2.5 μm. Percentages of cells with separated sister chromatids are shown in (C). For the control, cells were observed 30 min after nocodazole removal. Averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗, p < 0.05; ∗∗; p < 0.0001. (D and E) Cells of strain SCU1000 (CDC14-5GFP) were treated as described in Figure 1 C. Scale bar, 2.5 μm. Percentages of cells with diffused Cdc14 were determined and averages and SD from three independent experiments are shown in (E). For the control, cells were observed 30 min after nocodazole removal. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗∗∗∗, p <0.000001. (F) Five-fold serial dilutions of cells of strains SCU893 (wild type) and SCU1001 (cdc14-1) were spotted in 1-μL drops onto YPAD plates with or without 10 ng/mL rapamycin. The plates were incubated at 25°C for 3 days. An unrelated atg1Δ strain (SCU4067) defective in autophagy was used as the control. (G) Model of Cdc14 mediating TORC1 inactivation-induced anaphase onset. The inactivation of TORC1 sequentially causes Cdc14 activation, APC/C-Cdh1 activation, securin degradation, and anaphase onset.

    Techniques Used: Western Blot, Incubation, Two Tailed Test, Activation Assay

    mTORC1 inactivation elicits mitotic slippage (A) A schematic of the experimental procedure. (B) Phase-contrast time-lapse imaging of nocodazole-treated A549 cells. An example representing each category of cell fate to classify cells in <xref ref-type=Figure S4 A is shown. Numbers show elapsed time (hour:minute) relative to the start of imaging. Scale bar, 50 μm. (C) Fate of nocodazole-treated A549 cells with or without rapamycin treatment after 60-h imaging. Proportion of cells classified into each category, obtained by averaging the results of four independent experiments shown in Figure S4 A, is presented. Error bars represent standard errors. (D) Rate of mitotic slippage in nocodazole-treated A549 cells with or without rapamycin treatment and/or Cdh1 depletion. Percentage of cells that underwent mitotic slippage among the cells that underwent mitotic cell death or mitotic slippage, obtained by averaging the results of four independent experiments that are shown as dots, is presented. Error bars represent standard errors. ∗∗, p <0.01; ∗∗∗, p <0.001 (Tukey's multiple comparison test). ns, not statistically significant. (E) Duration of mitosis in nocodazole-treated A549 cells that underwent mitotic cell death or mitotic slippage. The results are average of four independent experiments. The results of rare mitotic slippage events in cells depleted of Cdc20 with or without Cdh1 were not shown. Error bars represent standard errors. ∗∗∗, p <0.001 (Tukey's multiple comparison test, comparison with Mock -Rap, mitotic cell death). (F) Duration of interphase after mitotic slippage in nocodazole-treated A549 cells with or without rapamycin treatment and/or Cdh1 depletion. The results are average of four independent experiments, which are shown as dots. Error bars represent standard errors. ∗∗, p <0.01 (Tukey's multiple comparison test). ns, not statistically significant. " title="... A549 cells with or without rapamycin treatment and/or Cdh1 depletion. Percentage of cells that underwent mitotic slippage ..." property="contentUrl" width="100%" height="100%"/>
    Figure Legend Snippet: mTORC1 inactivation elicits mitotic slippage (A) A schematic of the experimental procedure. (B) Phase-contrast time-lapse imaging of nocodazole-treated A549 cells. An example representing each category of cell fate to classify cells in Figure S4 A is shown. Numbers show elapsed time (hour:minute) relative to the start of imaging. Scale bar, 50 μm. (C) Fate of nocodazole-treated A549 cells with or without rapamycin treatment after 60-h imaging. Proportion of cells classified into each category, obtained by averaging the results of four independent experiments shown in Figure S4 A, is presented. Error bars represent standard errors. (D) Rate of mitotic slippage in nocodazole-treated A549 cells with or without rapamycin treatment and/or Cdh1 depletion. Percentage of cells that underwent mitotic slippage among the cells that underwent mitotic cell death or mitotic slippage, obtained by averaging the results of four independent experiments that are shown as dots, is presented. Error bars represent standard errors. ∗∗, p <0.01; ∗∗∗, p <0.001 (Tukey's multiple comparison test). ns, not statistically significant. (E) Duration of mitosis in nocodazole-treated A549 cells that underwent mitotic cell death or mitotic slippage. The results are average of four independent experiments. The results of rare mitotic slippage events in cells depleted of Cdc20 with or without Cdh1 were not shown. Error bars represent standard errors. ∗∗∗, p <0.001 (Tukey's multiple comparison test, comparison with Mock -Rap, mitotic cell death). (F) Duration of interphase after mitotic slippage in nocodazole-treated A549 cells with or without rapamycin treatment and/or Cdh1 depletion. The results are average of four independent experiments, which are shown as dots. Error bars represent standard errors. ∗∗, p <0.01 (Tukey's multiple comparison test). ns, not statistically significant.

    Techniques Used: Imaging


    Figure Legend Snippet:

    Techniques Used: Recombinant, Western Blot, Sequencing, Plasmid Preparation, Software

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93
    Bio-Techne corporation cleaved caspase3
    Cleaved Caspase3, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cleaved caspase3/product/Bio-Techne corporation
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    cleaved caspase3 - by Bioz Stars, 2024-09
    93/100 stars
      Buy from Supplier

    92
    ATCC haltrich 2007 thermus sp
    Haltrich 2007 Thermus Sp, supplied by ATCC, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/haltrich 2007 thermus sp/product/ATCC
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    haltrich 2007 thermus sp - by Bioz Stars, 2024-09
    92/100 stars
      Buy from Supplier

    86
    Thermo Fisher emd 15840
    Emd 15840, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/emd 15840/product/Thermo Fisher
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    emd 15840 - by Bioz Stars, 2024-09
    86/100 stars
      Buy from Supplier

    91
    Novus Biologicals rabbit polyclonal anti cdh1
    <t>APC/C-Cdh1</t> mediates TORC1 inactivation-induced anaphase onset (A) Cells of strain SCU1712 (CLB5-TAP) were treated as described in <xref ref-type=Figure 1 A. TAP-tagged cyclin B5 (Clb5) was detected by western blotting analysis using the anti-TAP antibody (PAP). (B–D) Cells of strains SCU1485 (BUB1-GFP) and SCU1337 (MAD2-GFP) harboring plasmid pSCU1701 (pMTW1-RFP) were treated as described in Figure 1 C. Bub1-GFP and Mad2-GFP signals were captured with Mtw1-RFP (a kinetochore marker) signals. Scale bar, 2.5 μm. Percentages of cells with Bub1-GFP or Mad2-GFP on the kinetochore were determined, and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ns, not statistically significant. (E) Cells of strains SCU2755 (PDS1-3HA) and SCU2693 (PDS1-3HA cdc20-3) precultured at 25°C were arrested in metaphase by nocodazole treatment for 3 h and transferred to 37°C for 30 min. Thereafter, cells were treated with rapamycin (+Rap) or released into nocodazole-free media (-Noc) (Time 0). Cells of strain SCU2282 (PDS1-3HA cdh1Δ) were treated as described in Figure 1 A. For comparison, see Figure 1 A, WT. 3HA-tagged securin Pds1 was detected by western blotting analysis using the anti-HA antibody. (F) Cells of strains SCU69 (CEN4-GFP) and SCU2114 (CEN4-GFP cdh1Δ) were treated as described in Figure 1 C. Scale bar, 2.5 μm. Percentages of cells with separated sister chromatids were determined and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗, p <0.05. (G) Five-fold serial dilutions of cells were spotted in 1-μL drops onto YPAD plates with or without 5 ng/mL rapamycin. The plates were incubated at 30°C for 1 day for YPAD plates and 2 days for rapamycin-containing YPAD plates. The yeast strains SCU893 (wild type) and SCU1228 (cdh1Δ) were used. (H) Model of APC/C-Cdh1 mediating TORC1 inactivation-induced anaphase onset. The inactivation of TORC1 sequentially causes APC/C-Cdh1 activation, degradation of securin and cyclin B5, and anaphase onset. " width="250" height="auto" />
    Rabbit Polyclonal Anti Cdh1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti cdh1/product/Novus Biologicals
    Average 91 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    rabbit polyclonal anti cdh1 - by Bioz Stars, 2024-09
    91/100 stars
      Buy from Supplier

    92
    Addgene inc pypq144
    <t>APC/C-Cdh1</t> mediates TORC1 inactivation-induced anaphase onset (A) Cells of strain SCU1712 (CLB5-TAP) were treated as described in <xref ref-type=Figure 1 A. TAP-tagged cyclin B5 (Clb5) was detected by western blotting analysis using the anti-TAP antibody (PAP). (B–D) Cells of strains SCU1485 (BUB1-GFP) and SCU1337 (MAD2-GFP) harboring plasmid pSCU1701 (pMTW1-RFP) were treated as described in Figure 1 C. Bub1-GFP and Mad2-GFP signals were captured with Mtw1-RFP (a kinetochore marker) signals. Scale bar, 2.5 μm. Percentages of cells with Bub1-GFP or Mad2-GFP on the kinetochore were determined, and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ns, not statistically significant. (E) Cells of strains SCU2755 (PDS1-3HA) and SCU2693 (PDS1-3HA cdc20-3) precultured at 25°C were arrested in metaphase by nocodazole treatment for 3 h and transferred to 37°C for 30 min. Thereafter, cells were treated with rapamycin (+Rap) or released into nocodazole-free media (-Noc) (Time 0). Cells of strain SCU2282 (PDS1-3HA cdh1Δ) were treated as described in Figure 1 A. For comparison, see Figure 1 A, WT. 3HA-tagged securin Pds1 was detected by western blotting analysis using the anti-HA antibody. (F) Cells of strains SCU69 (CEN4-GFP) and SCU2114 (CEN4-GFP cdh1Δ) were treated as described in Figure 1 C. Scale bar, 2.5 μm. Percentages of cells with separated sister chromatids were determined and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗, p <0.05. (G) Five-fold serial dilutions of cells were spotted in 1-μL drops onto YPAD plates with or without 5 ng/mL rapamycin. The plates were incubated at 30°C for 1 day for YPAD plates and 2 days for rapamycin-containing YPAD plates. The yeast strains SCU893 (wild type) and SCU1228 (cdh1Δ) were used. (H) Model of APC/C-Cdh1 mediating TORC1 inactivation-induced anaphase onset. The inactivation of TORC1 sequentially causes APC/C-Cdh1 activation, degradation of securin and cyclin B5, and anaphase onset. " width="250" height="auto" />
    Pypq144, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pypq144/product/Addgene inc
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    pypq144 - by Bioz Stars, 2024-09
    92/100 stars
      Buy from Supplier

    92
    Addgene inc pypq145
    <t>APC/C-Cdh1</t> mediates TORC1 inactivation-induced anaphase onset (A) Cells of strain SCU1712 (CLB5-TAP) were treated as described in <xref ref-type=Figure 1 A. TAP-tagged cyclin B5 (Clb5) was detected by western blotting analysis using the anti-TAP antibody (PAP). (B–D) Cells of strains SCU1485 (BUB1-GFP) and SCU1337 (MAD2-GFP) harboring plasmid pSCU1701 (pMTW1-RFP) were treated as described in Figure 1 C. Bub1-GFP and Mad2-GFP signals were captured with Mtw1-RFP (a kinetochore marker) signals. Scale bar, 2.5 μm. Percentages of cells with Bub1-GFP or Mad2-GFP on the kinetochore were determined, and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ns, not statistically significant. (E) Cells of strains SCU2755 (PDS1-3HA) and SCU2693 (PDS1-3HA cdc20-3) precultured at 25°C were arrested in metaphase by nocodazole treatment for 3 h and transferred to 37°C for 30 min. Thereafter, cells were treated with rapamycin (+Rap) or released into nocodazole-free media (-Noc) (Time 0). Cells of strain SCU2282 (PDS1-3HA cdh1Δ) were treated as described in Figure 1 A. For comparison, see Figure 1 A, WT. 3HA-tagged securin Pds1 was detected by western blotting analysis using the anti-HA antibody. (F) Cells of strains SCU69 (CEN4-GFP) and SCU2114 (CEN4-GFP cdh1Δ) were treated as described in Figure 1 C. Scale bar, 2.5 μm. Percentages of cells with separated sister chromatids were determined and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗, p <0.05. (G) Five-fold serial dilutions of cells were spotted in 1-μL drops onto YPAD plates with or without 5 ng/mL rapamycin. The plates were incubated at 30°C for 1 day for YPAD plates and 2 days for rapamycin-containing YPAD plates. The yeast strains SCU893 (wild type) and SCU1228 (cdh1Δ) were used. (H) Model of APC/C-Cdh1 mediating TORC1 inactivation-induced anaphase onset. The inactivation of TORC1 sequentially causes APC/C-Cdh1 activation, degradation of securin and cyclin B5, and anaphase onset. " width="250" height="auto" />
    Pypq145, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pypq145/product/Addgene inc
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    pypq145 - by Bioz Stars, 2024-09
    92/100 stars
      Buy from Supplier

    92
    Addgene inc pypq141 zmubi rz aac
    <t>APC/C-Cdh1</t> mediates TORC1 inactivation-induced anaphase onset (A) Cells of strain SCU1712 (CLB5-TAP) were treated as described in <xref ref-type=Figure 1 A. TAP-tagged cyclin B5 (Clb5) was detected by western blotting analysis using the anti-TAP antibody (PAP). (B–D) Cells of strains SCU1485 (BUB1-GFP) and SCU1337 (MAD2-GFP) harboring plasmid pSCU1701 (pMTW1-RFP) were treated as described in Figure 1 C. Bub1-GFP and Mad2-GFP signals were captured with Mtw1-RFP (a kinetochore marker) signals. Scale bar, 2.5 μm. Percentages of cells with Bub1-GFP or Mad2-GFP on the kinetochore were determined, and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ns, not statistically significant. (E) Cells of strains SCU2755 (PDS1-3HA) and SCU2693 (PDS1-3HA cdc20-3) precultured at 25°C were arrested in metaphase by nocodazole treatment for 3 h and transferred to 37°C for 30 min. Thereafter, cells were treated with rapamycin (+Rap) or released into nocodazole-free media (-Noc) (Time 0). Cells of strain SCU2282 (PDS1-3HA cdh1Δ) were treated as described in Figure 1 A. For comparison, see Figure 1 A, WT. 3HA-tagged securin Pds1 was detected by western blotting analysis using the anti-HA antibody. (F) Cells of strains SCU69 (CEN4-GFP) and SCU2114 (CEN4-GFP cdh1Δ) were treated as described in Figure 1 C. Scale bar, 2.5 μm. Percentages of cells with separated sister chromatids were determined and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗, p <0.05. (G) Five-fold serial dilutions of cells were spotted in 1-μL drops onto YPAD plates with or without 5 ng/mL rapamycin. The plates were incubated at 30°C for 1 day for YPAD plates and 2 days for rapamycin-containing YPAD plates. The yeast strains SCU893 (wild type) and SCU1228 (cdh1Δ) were used. (H) Model of APC/C-Cdh1 mediating TORC1 inactivation-induced anaphase onset. The inactivation of TORC1 sequentially causes APC/C-Cdh1 activation, degradation of securin and cyclin B5, and anaphase onset. " width="250" height="auto" />
    Pypq141 Zmubi Rz Aac, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pypq141 zmubi rz aac/product/Addgene inc
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    pypq141 zmubi rz aac - by Bioz Stars, 2024-09
    92/100 stars
      Buy from Supplier

    92
    Addgene inc pypq143
    <t>APC/C-Cdh1</t> mediates TORC1 inactivation-induced anaphase onset (A) Cells of strain SCU1712 (CLB5-TAP) were treated as described in <xref ref-type=Figure 1 A. TAP-tagged cyclin B5 (Clb5) was detected by western blotting analysis using the anti-TAP antibody (PAP). (B–D) Cells of strains SCU1485 (BUB1-GFP) and SCU1337 (MAD2-GFP) harboring plasmid pSCU1701 (pMTW1-RFP) were treated as described in Figure 1 C. Bub1-GFP and Mad2-GFP signals were captured with Mtw1-RFP (a kinetochore marker) signals. Scale bar, 2.5 μm. Percentages of cells with Bub1-GFP or Mad2-GFP on the kinetochore were determined, and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ns, not statistically significant. (E) Cells of strains SCU2755 (PDS1-3HA) and SCU2693 (PDS1-3HA cdc20-3) precultured at 25°C were arrested in metaphase by nocodazole treatment for 3 h and transferred to 37°C for 30 min. Thereafter, cells were treated with rapamycin (+Rap) or released into nocodazole-free media (-Noc) (Time 0). Cells of strain SCU2282 (PDS1-3HA cdh1Δ) were treated as described in Figure 1 A. For comparison, see Figure 1 A, WT. 3HA-tagged securin Pds1 was detected by western blotting analysis using the anti-HA antibody. (F) Cells of strains SCU69 (CEN4-GFP) and SCU2114 (CEN4-GFP cdh1Δ) were treated as described in Figure 1 C. Scale bar, 2.5 μm. Percentages of cells with separated sister chromatids were determined and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗, p <0.05. (G) Five-fold serial dilutions of cells were spotted in 1-μL drops onto YPAD plates with or without 5 ng/mL rapamycin. The plates were incubated at 30°C for 1 day for YPAD plates and 2 days for rapamycin-containing YPAD plates. The yeast strains SCU893 (wild type) and SCU1228 (cdh1Δ) were used. (H) Model of APC/C-Cdh1 mediating TORC1 inactivation-induced anaphase onset. The inactivation of TORC1 sequentially causes APC/C-Cdh1 activation, degradation of securin and cyclin B5, and anaphase onset. " width="250" height="auto" />
    Pypq143, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pypq143/product/Addgene inc
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    pypq143 - by Bioz Stars, 2024-09
    92/100 stars
      Buy from Supplier

    92
    Addgene inc pypq141
    <t>APC/C-Cdh1</t> mediates TORC1 inactivation-induced anaphase onset (A) Cells of strain SCU1712 (CLB5-TAP) were treated as described in <xref ref-type=Figure 1 A. TAP-tagged cyclin B5 (Clb5) was detected by western blotting analysis using the anti-TAP antibody (PAP). (B–D) Cells of strains SCU1485 (BUB1-GFP) and SCU1337 (MAD2-GFP) harboring plasmid pSCU1701 (pMTW1-RFP) were treated as described in Figure 1 C. Bub1-GFP and Mad2-GFP signals were captured with Mtw1-RFP (a kinetochore marker) signals. Scale bar, 2.5 μm. Percentages of cells with Bub1-GFP or Mad2-GFP on the kinetochore were determined, and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ns, not statistically significant. (E) Cells of strains SCU2755 (PDS1-3HA) and SCU2693 (PDS1-3HA cdc20-3) precultured at 25°C were arrested in metaphase by nocodazole treatment for 3 h and transferred to 37°C for 30 min. Thereafter, cells were treated with rapamycin (+Rap) or released into nocodazole-free media (-Noc) (Time 0). Cells of strain SCU2282 (PDS1-3HA cdh1Δ) were treated as described in Figure 1 A. For comparison, see Figure 1 A, WT. 3HA-tagged securin Pds1 was detected by western blotting analysis using the anti-HA antibody. (F) Cells of strains SCU69 (CEN4-GFP) and SCU2114 (CEN4-GFP cdh1Δ) were treated as described in Figure 1 C. Scale bar, 2.5 μm. Percentages of cells with separated sister chromatids were determined and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗, p <0.05. (G) Five-fold serial dilutions of cells were spotted in 1-μL drops onto YPAD plates with or without 5 ng/mL rapamycin. The plates were incubated at 30°C for 1 day for YPAD plates and 2 days for rapamycin-containing YPAD plates. The yeast strains SCU893 (wild type) and SCU1228 (cdh1Δ) were used. (H) Model of APC/C-Cdh1 mediating TORC1 inactivation-induced anaphase onset. The inactivation of TORC1 sequentially causes APC/C-Cdh1 activation, degradation of securin and cyclin B5, and anaphase onset. " width="250" height="auto" />
    Pypq141, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pypq141/product/Addgene inc
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    pypq141 - by Bioz Stars, 2024-09
    92/100 stars
      Buy from Supplier

    92
    Addgene inc pypq146
    <t>APC/C-Cdh1</t> mediates TORC1 inactivation-induced anaphase onset (A) Cells of strain SCU1712 (CLB5-TAP) were treated as described in <xref ref-type=Figure 1 A. TAP-tagged cyclin B5 (Clb5) was detected by western blotting analysis using the anti-TAP antibody (PAP). (B–D) Cells of strains SCU1485 (BUB1-GFP) and SCU1337 (MAD2-GFP) harboring plasmid pSCU1701 (pMTW1-RFP) were treated as described in Figure 1 C. Bub1-GFP and Mad2-GFP signals were captured with Mtw1-RFP (a kinetochore marker) signals. Scale bar, 2.5 μm. Percentages of cells with Bub1-GFP or Mad2-GFP on the kinetochore were determined, and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ns, not statistically significant. (E) Cells of strains SCU2755 (PDS1-3HA) and SCU2693 (PDS1-3HA cdc20-3) precultured at 25°C were arrested in metaphase by nocodazole treatment for 3 h and transferred to 37°C for 30 min. Thereafter, cells were treated with rapamycin (+Rap) or released into nocodazole-free media (-Noc) (Time 0). Cells of strain SCU2282 (PDS1-3HA cdh1Δ) were treated as described in Figure 1 A. For comparison, see Figure 1 A, WT. 3HA-tagged securin Pds1 was detected by western blotting analysis using the anti-HA antibody. (F) Cells of strains SCU69 (CEN4-GFP) and SCU2114 (CEN4-GFP cdh1Δ) were treated as described in Figure 1 C. Scale bar, 2.5 μm. Percentages of cells with separated sister chromatids were determined and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗, p <0.05. (G) Five-fold serial dilutions of cells were spotted in 1-μL drops onto YPAD plates with or without 5 ng/mL rapamycin. The plates were incubated at 30°C for 1 day for YPAD plates and 2 days for rapamycin-containing YPAD plates. The yeast strains SCU893 (wild type) and SCU1228 (cdh1Δ) were used. (H) Model of APC/C-Cdh1 mediating TORC1 inactivation-induced anaphase onset. The inactivation of TORC1 sequentially causes APC/C-Cdh1 activation, degradation of securin and cyclin B5, and anaphase onset. " width="250" height="auto" />
    Pypq146, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pypq146/product/Addgene inc
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    pypq146 - by Bioz Stars, 2024-09
    92/100 stars
      Buy from Supplier

    Image Search Results


    APC/C-Cdh1 mediates TORC1 inactivation-induced anaphase onset (A) Cells of strain SCU1712 (CLB5-TAP) were treated as described in <xref ref-type=Figure 1 A. TAP-tagged cyclin B5 (Clb5) was detected by western blotting analysis using the anti-TAP antibody (PAP). (B–D) Cells of strains SCU1485 (BUB1-GFP) and SCU1337 (MAD2-GFP) harboring plasmid pSCU1701 (pMTW1-RFP) were treated as described in Figure 1 C. Bub1-GFP and Mad2-GFP signals were captured with Mtw1-RFP (a kinetochore marker) signals. Scale bar, 2.5 μm. Percentages of cells with Bub1-GFP or Mad2-GFP on the kinetochore were determined, and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ns, not statistically significant. (E) Cells of strains SCU2755 (PDS1-3HA) and SCU2693 (PDS1-3HA cdc20-3) precultured at 25°C were arrested in metaphase by nocodazole treatment for 3 h and transferred to 37°C for 30 min. Thereafter, cells were treated with rapamycin (+Rap) or released into nocodazole-free media (-Noc) (Time 0). Cells of strain SCU2282 (PDS1-3HA cdh1Δ) were treated as described in Figure 1 A. For comparison, see Figure 1 A, WT. 3HA-tagged securin Pds1 was detected by western blotting analysis using the anti-HA antibody. (F) Cells of strains SCU69 (CEN4-GFP) and SCU2114 (CEN4-GFP cdh1Δ) were treated as described in Figure 1 C. Scale bar, 2.5 μm. Percentages of cells with separated sister chromatids were determined and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗, p <0.05. (G) Five-fold serial dilutions of cells were spotted in 1-μL drops onto YPAD plates with or without 5 ng/mL rapamycin. The plates were incubated at 30°C for 1 day for YPAD plates and 2 days for rapamycin-containing YPAD plates. The yeast strains SCU893 (wild type) and SCU1228 (cdh1Δ) were used. (H) Model of APC/C-Cdh1 mediating TORC1 inactivation-induced anaphase onset. The inactivation of TORC1 sequentially causes APC/C-Cdh1 activation, degradation of securin and cyclin B5, and anaphase onset. " width="100%" height="100%">

    Journal: iScience

    Article Title: TORC1 inactivation promotes APC/C-dependent mitotic slippage in yeast and human cells

    doi: 10.1016/j.isci.2021.103675

    Figure Lengend Snippet: APC/C-Cdh1 mediates TORC1 inactivation-induced anaphase onset (A) Cells of strain SCU1712 (CLB5-TAP) were treated as described in Figure 1 A. TAP-tagged cyclin B5 (Clb5) was detected by western blotting analysis using the anti-TAP antibody (PAP). (B–D) Cells of strains SCU1485 (BUB1-GFP) and SCU1337 (MAD2-GFP) harboring plasmid pSCU1701 (pMTW1-RFP) were treated as described in Figure 1 C. Bub1-GFP and Mad2-GFP signals were captured with Mtw1-RFP (a kinetochore marker) signals. Scale bar, 2.5 μm. Percentages of cells with Bub1-GFP or Mad2-GFP on the kinetochore were determined, and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ns, not statistically significant. (E) Cells of strains SCU2755 (PDS1-3HA) and SCU2693 (PDS1-3HA cdc20-3) precultured at 25°C were arrested in metaphase by nocodazole treatment for 3 h and transferred to 37°C for 30 min. Thereafter, cells were treated with rapamycin (+Rap) or released into nocodazole-free media (-Noc) (Time 0). Cells of strain SCU2282 (PDS1-3HA cdh1Δ) were treated as described in Figure 1 A. For comparison, see Figure 1 A, WT. 3HA-tagged securin Pds1 was detected by western blotting analysis using the anti-HA antibody. (F) Cells of strains SCU69 (CEN4-GFP) and SCU2114 (CEN4-GFP cdh1Δ) were treated as described in Figure 1 C. Scale bar, 2.5 μm. Percentages of cells with separated sister chromatids were determined and averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗, p <0.05. (G) Five-fold serial dilutions of cells were spotted in 1-μL drops onto YPAD plates with or without 5 ng/mL rapamycin. The plates were incubated at 30°C for 1 day for YPAD plates and 2 days for rapamycin-containing YPAD plates. The yeast strains SCU893 (wild type) and SCU1228 (cdh1Δ) were used. (H) Model of APC/C-Cdh1 mediating TORC1 inactivation-induced anaphase onset. The inactivation of TORC1 sequentially causes APC/C-Cdh1 activation, degradation of securin and cyclin B5, and anaphase onset.

    Article Snippet: Rabbit polyclonal anti-Cdh1 , Novus Biologicals , Cat#NBP2-15840; RRID: AB_2895137 , .

    Techniques: Western Blot, Plasmid Preparation, Marker, Two Tailed Test, Incubation, Activation Assay

    Cdc14 mediates TORC1 inactivation-induced anaphase onset (A) Cells of strain SCU3250 (PDS1-3HA cdc14-1) were treated as described in <xref ref-type=Figure 2 E. 3HA-tagged securin Pds1 was detected by western blotting analysis using the anti-HA antibody. (B and C) Cells of strains SCU69 (CEN4-GFP) and SCU3204 (CEN4-GFP cdc14-1) preincubated at 25°C were arrested in metaphase by nocodazole treatment for 3 h and then transferred to 37°C for 30 min. Thereafter, the cells were further incubated with or without rapamycin for 1 h. Scale bar, 2.5 μm. Percentages of cells with separated sister chromatids are shown in (C). For the control, cells were observed 30 min after nocodazole removal. Averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗, p < 0.05; ∗∗; p < 0.0001. (D and E) Cells of strain SCU1000 (CDC14-5GFP) were treated as described in Figure 1 C. Scale bar, 2.5 μm. Percentages of cells with diffused Cdc14 were determined and averages and SD from three independent experiments are shown in (E). For the control, cells were observed 30 min after nocodazole removal. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗∗∗∗, p <0.000001. (F) Five-fold serial dilutions of cells of strains SCU893 (wild type) and SCU1001 (cdc14-1) were spotted in 1-μL drops onto YPAD plates with or without 10 ng/mL rapamycin. The plates were incubated at 25°C for 3 days. An unrelated atg1Δ strain (SCU4067) defective in autophagy was used as the control. (G) Model of Cdc14 mediating TORC1 inactivation-induced anaphase onset. The inactivation of TORC1 sequentially causes Cdc14 activation, APC/C-Cdh1 activation, securin degradation, and anaphase onset. " width="100%" height="100%">

    Journal: iScience

    Article Title: TORC1 inactivation promotes APC/C-dependent mitotic slippage in yeast and human cells

    doi: 10.1016/j.isci.2021.103675

    Figure Lengend Snippet: Cdc14 mediates TORC1 inactivation-induced anaphase onset (A) Cells of strain SCU3250 (PDS1-3HA cdc14-1) were treated as described in Figure 2 E. 3HA-tagged securin Pds1 was detected by western blotting analysis using the anti-HA antibody. (B and C) Cells of strains SCU69 (CEN4-GFP) and SCU3204 (CEN4-GFP cdc14-1) preincubated at 25°C were arrested in metaphase by nocodazole treatment for 3 h and then transferred to 37°C for 30 min. Thereafter, the cells were further incubated with or without rapamycin for 1 h. Scale bar, 2.5 μm. Percentages of cells with separated sister chromatids are shown in (C). For the control, cells were observed 30 min after nocodazole removal. Averages and error bars from two independent experiments are shown. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗, p < 0.05; ∗∗; p < 0.0001. (D and E) Cells of strain SCU1000 (CDC14-5GFP) were treated as described in Figure 1 C. Scale bar, 2.5 μm. Percentages of cells with diffused Cdc14 were determined and averages and SD from three independent experiments are shown in (E). For the control, cells were observed 30 min after nocodazole removal. Statistical analyses were carried out using the two-tailed Fisher's exact test. ∗∗∗∗, p <0.000001. (F) Five-fold serial dilutions of cells of strains SCU893 (wild type) and SCU1001 (cdc14-1) were spotted in 1-μL drops onto YPAD plates with or without 10 ng/mL rapamycin. The plates were incubated at 25°C for 3 days. An unrelated atg1Δ strain (SCU4067) defective in autophagy was used as the control. (G) Model of Cdc14 mediating TORC1 inactivation-induced anaphase onset. The inactivation of TORC1 sequentially causes Cdc14 activation, APC/C-Cdh1 activation, securin degradation, and anaphase onset.

    Article Snippet: Rabbit polyclonal anti-Cdh1 , Novus Biologicals , Cat#NBP2-15840; RRID: AB_2895137 , .

    Techniques: Western Blot, Incubation, Two Tailed Test, Activation Assay

    mTORC1 inactivation elicits mitotic slippage (A) A schematic of the experimental procedure. (B) Phase-contrast time-lapse imaging of nocodazole-treated A549 cells. An example representing each category of cell fate to classify cells in <xref ref-type=Figure S4 A is shown. Numbers show elapsed time (hour:minute) relative to the start of imaging. Scale bar, 50 μm. (C) Fate of nocodazole-treated A549 cells with or without rapamycin treatment after 60-h imaging. Proportion of cells classified into each category, obtained by averaging the results of four independent experiments shown in Figure S4 A, is presented. Error bars represent standard errors. (D) Rate of mitotic slippage in nocodazole-treated A549 cells with or without rapamycin treatment and/or Cdh1 depletion. Percentage of cells that underwent mitotic slippage among the cells that underwent mitotic cell death or mitotic slippage, obtained by averaging the results of four independent experiments that are shown as dots, is presented. Error bars represent standard errors. ∗∗, p <0.01; ∗∗∗, p <0.001 (Tukey's multiple comparison test). ns, not statistically significant. (E) Duration of mitosis in nocodazole-treated A549 cells that underwent mitotic cell death or mitotic slippage. The results are average of four independent experiments. The results of rare mitotic slippage events in cells depleted of Cdc20 with or without Cdh1 were not shown. Error bars represent standard errors. ∗∗∗, p <0.001 (Tukey's multiple comparison test, comparison with Mock -Rap, mitotic cell death). (F) Duration of interphase after mitotic slippage in nocodazole-treated A549 cells with or without rapamycin treatment and/or Cdh1 depletion. The results are average of four independent experiments, which are shown as dots. Error bars represent standard errors. ∗∗, p <0.01 (Tukey's multiple comparison test). ns, not statistically significant. " width="100%" height="100%">

    Journal: iScience

    Article Title: TORC1 inactivation promotes APC/C-dependent mitotic slippage in yeast and human cells

    doi: 10.1016/j.isci.2021.103675

    Figure Lengend Snippet: mTORC1 inactivation elicits mitotic slippage (A) A schematic of the experimental procedure. (B) Phase-contrast time-lapse imaging of nocodazole-treated A549 cells. An example representing each category of cell fate to classify cells in Figure S4 A is shown. Numbers show elapsed time (hour:minute) relative to the start of imaging. Scale bar, 50 μm. (C) Fate of nocodazole-treated A549 cells with or without rapamycin treatment after 60-h imaging. Proportion of cells classified into each category, obtained by averaging the results of four independent experiments shown in Figure S4 A, is presented. Error bars represent standard errors. (D) Rate of mitotic slippage in nocodazole-treated A549 cells with or without rapamycin treatment and/or Cdh1 depletion. Percentage of cells that underwent mitotic slippage among the cells that underwent mitotic cell death or mitotic slippage, obtained by averaging the results of four independent experiments that are shown as dots, is presented. Error bars represent standard errors. ∗∗, p <0.01; ∗∗∗, p <0.001 (Tukey's multiple comparison test). ns, not statistically significant. (E) Duration of mitosis in nocodazole-treated A549 cells that underwent mitotic cell death or mitotic slippage. The results are average of four independent experiments. The results of rare mitotic slippage events in cells depleted of Cdc20 with or without Cdh1 were not shown. Error bars represent standard errors. ∗∗∗, p <0.001 (Tukey's multiple comparison test, comparison with Mock -Rap, mitotic cell death). (F) Duration of interphase after mitotic slippage in nocodazole-treated A549 cells with or without rapamycin treatment and/or Cdh1 depletion. The results are average of four independent experiments, which are shown as dots. Error bars represent standard errors. ∗∗, p <0.01 (Tukey's multiple comparison test). ns, not statistically significant.

    Article Snippet: Rabbit polyclonal anti-Cdh1 , Novus Biologicals , Cat#NBP2-15840; RRID: AB_2895137 , .

    Techniques: Imaging

    Journal: iScience

    Article Title: TORC1 inactivation promotes APC/C-dependent mitotic slippage in yeast and human cells

    doi: 10.1016/j.isci.2021.103675

    Figure Lengend Snippet:

    Article Snippet: Rabbit polyclonal anti-Cdh1 , Novus Biologicals , Cat#NBP2-15840; RRID: AB_2895137 , .

    Techniques: Recombinant, Western Blot, Sequencing, Plasmid Preparation, Software